EU’s CHMP Gives Nod To First Biosimilar Epoetin Alfa Formulations
This article was originally published in The Pink Sheet Daily
Executive Summary
Sandoz is set to launch its biosimilar, Binocrit, in 2007 following commission approval, the firm tells “The Pink Sheet” DAILY.